Transvalvular Flow Rate Determines Prognostic Value of Aortic Valve Area in Aortic Stenosis.


Journal

Journal of the American College of Cardiology
ISSN: 1558-3597
Titre abrégé: J Am Coll Cardiol
Pays: United States
ID NLM: 8301365

Informations de publication

Date de publication:
21 04 2020
Historique:
received: 19 12 2019
revised: 01 02 2020
accepted: 14 02 2020
entrez: 18 4 2020
pubmed: 18 4 2020
medline: 29 12 2020
Statut: ppublish

Résumé

Aortic valve area (AVA) ≤1.0 cm This study aimed to evaluate the effect of flow rate on prognostic value of AVA in AS. In total, 1,131 patients with moderate or severe AS and complete clinical follow-up were included as part of a longitudinal database. The effect of flow rate (ratio of stroke volume to ejection time) on prognostic value of AVA ≤1.0 cm Flow rate had a significant effect on prognostic value of AVA. AVA ≤1.0 cm Transvalvular flow rate determines prognostic value of AVA in AS. AVA measured at low flow rate is not a good prognostic marker and therefore not a good diagnostic marker for truly severe AS. Flow rate assessment should be incorporated into clinical diagnosis, classification, and prognosis of AS.

Sections du résumé

BACKGROUND
Aortic valve area (AVA) ≤1.0 cm
OBJECTIVES
This study aimed to evaluate the effect of flow rate on prognostic value of AVA in AS.
METHODS
In total, 1,131 patients with moderate or severe AS and complete clinical follow-up were included as part of a longitudinal database. The effect of flow rate (ratio of stroke volume to ejection time) on prognostic value of AVA ≤1.0 cm
RESULTS
Flow rate had a significant effect on prognostic value of AVA. AVA ≤1.0 cm
CONCLUSIONS
Transvalvular flow rate determines prognostic value of AVA in AS. AVA measured at low flow rate is not a good prognostic marker and therefore not a good diagnostic marker for truly severe AS. Flow rate assessment should be incorporated into clinical diagnosis, classification, and prognosis of AS.

Identifiants

pubmed: 32299587
pii: S0735-1097(20)34425-9
doi: 10.1016/j.jacc.2020.02.046
pmc: PMC8087111
mid: NIHMS1580385
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1758-1769

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL092101
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL141917
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL109506
Pays : United States
Organisme : CIHR
ID : FDN-143225
Pays : Canada
Organisme : CIHR
ID : MOP-114997
Pays : Canada
Organisme : NHLBI NIH HHS
ID : R01 HL128099
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL088942
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Références

Hypertension. 2018 Dec;72(6):1294-1300
pubmed: 30571228
N Engl J Med. 2019 May 2;380(18):1695-1705
pubmed: 30883058
JACC Cardiovasc Imaging. 2017 Aug;10(8):912-920
pubmed: 28797414
Eur Heart J. 2017 Sep 21;38(36):2739-2791
pubmed: 28886619
Am Heart J. 1973 Feb;85(2):227-36
pubmed: 4688832
Circulation. 1995 Feb 15;91(4):1196-204
pubmed: 7850959
Eur Heart J Cardiovasc Imaging. 2019 Oct 1;20(10):1094-1101
pubmed: 31327014
J Am Soc Echocardiogr. 1996 May-Jun;9(3):295-9
pubmed: 8736013
J Geriatr Cardiol. 2016 Dec;13(12):941-944
pubmed: 28321235
Eur J Appl Physiol Occup Physiol. 1984;52(3):282-6
pubmed: 6539679
Clin Cardiol. 1990 Sep;13(9):632-7
pubmed: 2208822
J Am Coll Cardiol. 2017 Jul 11;70(2):252-289
pubmed: 28315732
JACC Cardiovasc Imaging. 2019 Feb;12(2):267-282
pubmed: 30732722
Circulation. 2007 Jun 5;115(22):2856-64
pubmed: 17533183
Curr Treat Options Cardiovasc Med. 2018 Jun 19;20(7):52
pubmed: 29923126
Hypertension. 2011 Feb;57(2):193-200
pubmed: 21173342
Heart. 2016 Jun 15;102(12):934-42
pubmed: 27048774
JACC Cardiovasc Imaging. 2019 Sep;12(9):1715-1724
pubmed: 29550315
Circ Cardiovasc Imaging. 2017 Dec;10(12):
pubmed: 29222124
J Am Coll Cardiol. 2012 Nov 6;60(19):1845-53
pubmed: 23062546
JACC Cardiovasc Imaging. 2015 Oct;8(10):1133-1139
pubmed: 26363832
Circulation. 2006 Feb 7;113(5):711-21
pubmed: 16461844
Eur Heart J. 2008 Oct;29(20):2526-35
pubmed: 18263866

Auteurs

Mayooran Namasivayam (M)

Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: https://twitter.com/MayoNamasivayam.

Wei He (W)

Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Timothy W Churchill (TW)

Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Romain Capoulade (R)

Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000, Nantes, France; Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.

Shiying Liu (S)

Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Hang Lee (H)

Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Jacqueline S Danik (JS)

Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Michael H Picard (MH)

Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Philippe Pibarot (P)

Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.

Robert A Levine (RA)

Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Judy Hung (J)

Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: jhung@mgh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH